A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter-Reference-Cited by-同舟云学术

A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter

Published:2022-05 Issue: Volume:109 Page:25-31
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Biggs M. Antonia^ORCID,Ralph Lauren,Morris Natalie^ORCID,Ehrenreich Katherine^ORCID,Perritt Jamila,Kapp Nathalie,Blanchard Kelly,White Kari^ORCID,Barar Rana^ORCID,Grossman Daniel^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference37 articles.

1. U.S. Food and Drug Administration. Mifeprex (mifepristone) Information 2021.

2. U.S. Food and Drug Administration. Mifeprex (mifepristone) information. Postmarket drug safety information for patients and providers; 2016. 2016.

3. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review;Abubeker;BMC Womens Health,2020

4. A research agenda for moving early medical pregnancy termination over the counter;Kapp;BJOG Int J Obstet Gynaecol,2017

5. Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women;Biggs;Contraception,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on Alternative Models of Medication Abortion Provision Among Abortion Patients in the United States;Women's Health Issues;2023-09

2. Pushing Back with Pills — Enhancing Access to Reproductive Health Drugs after Dobbs;New England Journal of Medicine;2022-09-22